Importantly, we reported a significant increase in gene expression of Chop in the livers of NASH patients, which correlated with priming of the inflammasome markers caspase-1, caspase-4 and IL-1β. The gene discussed is CASP1; the disease is metabolic dysfunction-associated steatohepatitis.